Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
MS: COVID-19, uitgesteld doseren natalizumab en nieuwe middelen
dec 2020 | Multipele Sclerose